Literature DB >> 31899576

Impact of Onset of Psychiatric Disorders and Psychiatric Treatment on Mortality Among Patients with Cancer.

Sang Ah Lee1,2,3, Chung Mo Nam4, Young Hoon Kim5, Tae Hyun Kim2,6, Sung-In Jang2,4, Eun-Cheol Park2,4.   

Abstract

BACKGROUND: Psychiatric disorders are common in patients with cancer. The impact of both psychiatric disorders and psychiatric treatment on mortality in patients with cancer needs to be established.
MATERIALS AND METHODS: Nationwide claims data were analyzed. To investigate the association between psychiatric disorders and mortality, 6,292 male and 4,455 female patients with cancer who did not have a record of psychiatric disorders before cancer onset were included. To examine the association between psychiatric treatment and mortality, 1,467 male and 1,364 female patients with cancer were included. Incident psychiatric disorder and receipt of psychiatric treatment within 30 days from the onset of a psychiatric disorder were the main independent variables. Dependent variables were all-cause and cancer-related mortality. Cox proportional hazards regression with time-dependent covariates was used.
RESULTS: The onset of psychiatric disorders was associated with a significantly increased risk of mortality in both male (all-cause hazard ratio [HR]: 1.55; cancer-related HR: 1.47) and female patients with cancer (all-cause HR: 1.50; cancer-related HR: 1.44) compared with patients with cancer without psychiatric disorders. Both male and female patients who received psychiatric treatment within 30 days of diagnosis of a psychiatric disorder had a lower risk of cancer-related mortality (males, HR: 0.73; females, HR: 0.71) compared with patients with cancer with psychiatric disorders who did not receive psychiatric treatment.
CONCLUSION: Patients with cancer with newly diagnosed psychiatric disorders had a higher mortality rate. Among these, those who received psychiatric treatment showed lower rates of mortality. Thus, early detection and early treatment of psychiatric disorders in patients with cancer is needed. IMPLICATIONS FOR PRACTICE: The current study supplements the body of evidence supporting the association of psychiatric disorders onset and treatment with cancer outcomes. Patients with cancer showed an increased risk of both all-cause and cancer-related mortality upon psychiatric disorder onset. Among patients with newly diagnosed psychiatric disorders, those who received psychiatric treatment showed lower cancer-related mortality. Thus, raising awareness of both the risk of psychiatric disorders and the positive effects of psychiatric treatment on cancer outcomes is necessary among patients with cancer, caregivers, and oncologists. Furthermore, it is necessary to adopt a multidisciplinary approach, encouraging patients with cancer to undergo a neuropsychological assessment of their mental health status and receive appropriate and timely psychological interventions. © AlphaMed Press 2020.

Entities:  

Keywords:  Cancer; Mortality; Psychiatric diagnosis; Psycho-oncology; Psychotherapy

Mesh:

Year:  2020        PMID: 31899576      PMCID: PMC7160313          DOI: 10.1634/theoncologist.2019-0396

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  53 in total

1.  Assessing and managing depression in the terminally ill patient. ACP-ASIM End-of-Life Care Consensus Panel. American College of Physicians - American Society of Internal Medicine.

Authors:  S D Block
Journal:  Ann Intern Med       Date:  2000-02-01       Impact factor: 25.391

2.  Psychological morbidity and quality of life in women with advanced breast cancer: a cross-sectional survey.

Authors:  Brenda Grabsch; David M Clarke; Anthony Love; Dean P McKenzie; Raymond D Snyder; Sidney Bloch; Graeme Smith; David W Kissane
Journal:  Palliat Support Care       Date:  2006-03

3.  Incidence of Diabetes After Cancer Development: A Korean National Cohort Study.

Authors:  Yul Hwangbo; Danbee Kang; Minwoong Kang; Saemina Kim; Eun Kyung Lee; Young Ae Kim; Yoon Jung Chang; Kui Son Choi; So-Youn Jung; Sang Myung Woo; Jin Seok Ahn; Sung Hoon Sim; Yun Soo Hong; Roberto Pastor-Barriuso; Eliseo Guallar; Eun Sook Lee; Sun-Young Kong; Juhee Cho
Journal:  JAMA Oncol       Date:  2018-08-01       Impact factor: 31.777

4.  Biobehavioral approaches to cancer progression and survival: Mechanisms and interventions.

Authors:  Susan K Lutgendorf; Barbara L Andersen
Journal:  Am Psychol       Date:  2015 Feb-Mar

5.  Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies.

Authors:  Alex J Mitchell; Melissa Chan; Henna Bhatti; Marie Halton; Luigi Grassi; Christoffer Johansen; Nicholas Meader
Journal:  Lancet Oncol       Date:  2011-01-19       Impact factor: 41.316

6.  Effect of stage, comorbidities and treatment on survival among cancer patients with or without mental illness.

Authors:  Kristiina Manderbacka; Martti Arffman; Jaana Suvisaari; Aulikki Ahlgren-Rimpiläinen; Sonja Lumme; Ilmo Keskimäki; Eero Pukkala
Journal:  Br J Psychiatry       Date:  2017-09-21       Impact factor: 9.319

7.  Psychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis.

Authors:  David W Kissane; Brenda Grabsch; Anthony Love; David M Clarke; Sidney Bloch; Graeme C Smith
Journal:  Aust N Z J Psychiatry       Date:  2004-05       Impact factor: 5.744

8.  Pre-intervention distress moderates the efficacy of psychosocial treatment for cancer patients: a meta-analysis.

Authors:  Stefan Schneider; Anne Moyer; Sarah Knapp-Oliver; Stephanie Sohl; Dolores Cannella; Valerie Targhetta
Journal:  J Behav Med       Date:  2009-09-27

9.  Excess cancer mortality in psychiatric patients.

Authors:  Stephen Kisely; Joseph Sadek; Adrian MacKenzie; David Lawrence; Leslie Anne Campbell
Journal:  Can J Psychiatry       Date:  2008-11       Impact factor: 4.356

10.  A cohort study on mental disorders, stage of cancer at diagnosis and subsequent survival.

Authors:  Chin-Kuo Chang; Richard D Hayes; Matthew T M Broadbent; Matthew Hotopf; Elizabeth Davies; Henrik Møller; Robert Stewart
Journal:  BMJ Open       Date:  2014-01-29       Impact factor: 2.692

View more
  5 in total

1.  Characterizing experiences of non-medical switching to trastuzumab biosimilars using data from internet-based surveys with US-based oncologists and breast cancer patients.

Authors:  Elizabeth Lerner Papautsky; Martha Carlson; Sheila M Johnson; Hannah Montague; Deanna J Attai; Maryam B Lustberg
Journal:  Breast Cancer Res Treat       Date:  2022-05-14       Impact factor: 4.624

2.  Predictors of mental health disorders in women with breast and gynecological cancer after radical surgery: A cross-sectional study.

Authors:  Amina Aquil; Ouassil El Kherchi; Naoual El Azmaoui; Mustapha Mouallif; Maroua Guerroumi; Abdellatif Benider; Abdeljalil Elgot
Journal:  Ann Med Surg (Lond)       Date:  2021-04-10

3.  Anxiety, Depression and Quality of Life in Patients with Neuroendocrine Neoplasia After Surgery.

Authors:  Nehara Begum; Hannah Hunold; Berthold Gerdes; Tobias Keck; Annika Waldmann
Journal:  World J Surg       Date:  2022-02-22       Impact factor: 3.282

4.  The impact of depression on survival of head and neck cancer patients: A population-based cohort study.

Authors:  Ren-Wen Huang; Kai-Ping Chang; Filippo Marchi; Charles Yuen Yung Loh; Yu-Jr Lin; Chee-Jen Chang; Huang-Kai Kao
Journal:  Front Oncol       Date:  2022-08-25       Impact factor: 5.738

5.  Psychotropic medication use in cancer patients- a Chinese perspective.

Authors:  Blánaid Hicks
Journal:  Lancet Reg Health West Pac       Date:  2020-12-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.